Login / Signup

Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.

Hamish E G McWilliamJeffrey Y W MakWael AwadMatthew ZorkauSebastian Cruz-GomezHui Jing LimYuting YanSam WormaldLaura F DagleySidonia Barbara Guiomar EckleAlexandra J CorbettHaiyin LiuShihan LiScott J J ReddiexJustine D MinternLigong LiuJames McCluskeyJamie RossjohnDavid P FairlieJose A Villadangos
Published in: Proceedings of the National Academy of Sciences of the United States of America (2020)
The antigen-presenting molecule MR1 (MHC class I-related protein 1) presents metabolite antigens derived from microbial vitamin B2 synthesis to activate mucosal-associated invariant T (MAIT) cells. Key aspects of this evolutionarily conserved pathway remain uncharacterized, including where MR1 acquires ligands and what accessory proteins assist ligand binding. We answer these questions by using a fluorophore-labeled stable MR1 antigen analog, a conformation-specific MR1 mAb, proteomic analysis, and a genome-wide CRISPR/Cas9 library screen. We show that the endoplasmic reticulum (ER) contains a pool of two unliganded MR1 conformers stabilized via interactions with chaperones tapasin and tapasin-related protein. This pool is the primary source of MR1 molecules for the presentation of exogenous metabolite antigens to MAIT cells. Deletion of these chaperones reduces the ER-resident MR1 pool and hampers antigen presentation and MAIT cell activation. The MR1 antigen-presentation pathway thus co-opts ER chaperones to fulfill its unique ability to present exogenous metabolite antigens captured within the ER.
Keyphrases